Abbott is a diversified health care company that discovers, develops, manufactures and markets innovative products and services that span the continuum of care – from prevention and diagnosis to treatment and cure.
Abbott is committed to the highest standards of quality and sustainability via stringent internal quality-control procedures and compliance with Good Manufacturing and Clinical Practice.
Abbott has been recognized since 1888 for turning science into caring.
Headquartered in north suburban Chicago, Abbott helps people around the world in the more than 130 countries.
Abbott started its operations in Egypt in 1946 operating through an agent In 1953 started registration of the scientific office, local manufacturing began in 1978.
Everything we do at AstraZeneca is driven by our commitment to improving the lives of patients. Whether that’s working to reach more people with our medicines, or applying our science skills to developing the next generation of treatments, or collaborating with others in the fight against disease, everything centres on understanding and meeting the needs of people facing serious health challenges.
Our five core values are the fundamental beliefs of AstraZeneca – they define how we expect to do business, are the reference point for our decision-making, and shape the culture that underpins our business success
Science for a better life
-Health Through Medical Progress The Bayer Group is a global enterprise with core competencies in the fields of health care, agriculture and high-tech materials. Bayer HealthCare, a subgroup of Bayer AG, innovative companies in the healthcare and medical products industry and is based in Leverkusen, Germany. The company combines the global activities of the Animal Health, Consumer Care, Medical Care and Pharmaceuticals divisions. Bayer HealthCare’s aim is to discover, develop, manufacture and market products that will improve human and animal health worldwide. Bayer HealthCare has a global workforce of 55,700 employees (Dec 31, 2011) and is represented in more than 100 countries.We aim to improve people’s quality of life with our products. To achieve this, we concentrate on the research and development of innovative drugs and novel therapeutic approaches. At the same time, we are constantly improving established products. In this context, Bayer HealthCare Pharmaceuticals uses experience it has gained from over a century in the business.
We concentrate on five big therapeutic groups in which we make essential contributions to medical progress:
* Cardiovascular and blood diseases, Oncological diseases, Ophthalmology, Women’s healthcare, Imaging techniques
Biofactor-Marcyrl pharmaceutical company was established on September 2007 under the Egyptian law for marketing & promoting ethical pharmaceutical products in the Egyptian market; it is one of the main marketing arms of Marcyrl group. Marcyrl group is one of the strongly established companies in the Egyptian market as per the IMS; Marcyrl group has successfully entered the “Top 20” among approximately 370 factories in Egypt & reached the rank number “11” among pharmaceutical factories in Egypt; besides it had the highest growth rate among the top 20 factories; PPG Value 51.8%.
Biofactor-Marcyrl Vision; “Affordable Quality is our Value”; our Ultimate goal & value is to supply your patients with High quality products of Marcyrl group with affordable prices; additionally we have now variety of products that satisfies several specialties especially Cardiology specialty; where we offer most advanced molecules in several strategic therapeutic areas like Hypertension; Heart Failure & Dyslipidemia.
Boston Scientific has been a leader in Cardiovascular Care since 1979. Our leadership position in Drug-eluting stents is supported by our multiple stent options such as TAXUS Liberte, TAXUS Element Paclitaxel Eluting Stent, PROMUS, PROMUS Element Everolimus- Eluting Stent, and a variety of Bare –Metal stents. In addition, we are a leader in the Cath Lab in the following area: Drug Eluting stents, Balloon Catheters, IVUS, Atherectomy, Embolic
protection, and Inflation Devices. Being a leader means a commitment to clinical science and evidencebased medicine. More than 50,000 patients have been studied to date in clinical trials and registries as part of our extensive clinical program. Being a leader means investing in the future. Every year, on average, we reinvest 13% of revenues into Research & Development in fulfillment of our promise to deliver what’s next. Being a leader means staying focused on your mission. Everyday around the world, 27,500 Boston Scientific employees dedicate themselves to helping physicians improve the quality of patient care. Making More Possible.
GE Healthcare provides transformational medical technologies and services, shaping a new age in patient care. To date, GE has over 7,500 healthcare technologies installed across Egypt that help bring better health to more people. In Egypt, GE is working with the Ministry of Health to develop a centralized image repository, which Egyptian hospitals use to send, share and store x-ray images to facilitate remote assessment. GE is linking six remote hospitals to a central reporting facility in Cairo, where radiologists and other specialists can view and diagnose scans. Urban specialists can connect with rural generalists via telemedicine, a key improvement in connecting skilled healthcare technicians to the patients that need them most. Egypt’s first new generation cyclotron production facility was implemented in July 2009 by GE Healthcare in partnership with the Children’s Cancer Hospital Egypt (CCHE), the largest pediatric oncology center of its kind in the Middle East and Africa. GE Healthcare has installed its PETtrace 6 cyclotron with a complete radiopharmacy suite at CCHE.
GE Healthcare supported the Egyptian National Breast Cancer Screening Program with GE’s digital mammography mobile systems in 2008. Digital mammography reading workshops were held for the first time in Egypt by GE at the Mediconex Updates on Breast Cancer and Women’s Imaging Symposium in Cairo.
GE Healthcare delivers high-quality images with accuracy through its PET/CT offerings. The advanced scanning technology provides the insight that physicians need to deliver effective disease detection, monitoring and treatment planning.
Alongside mammography and ultrasound technologies, SenoBright detects unusual blood flow patterns, which can be used to confirm findings and pinpoint lesions when screening results are inconclusive.
‘Innova is a leading Egyptian private company acting as sole agent for many multinational producers of medical devices.
We also provide a broad range of Coronary and peripheral stents, PCTA balloons, PTA balloons, Accessories, non-invasive diagnostic and invasive diagnostic cardiology devices.
Since its establishment,Innova has been focusing on providing premium service and high quality products.
With its projects as Innova heart center chain and the Stent facility, Innova hopes to raise the quality standards of healthcare offered in Egypt and to be a leader in the healthcare business in Egypt and Middle East.’
Merck Sharp &Dohme
At MSD, we work hard to keep the world well. How? By providing people all around the globe with innovative prescription medicines, vaccines, and consumer care and animal health products. We also provide leading healthcare solutions that make a difference. And we do it by listening to patients, physicians and our other partners — and anticipating their needs.
We believe our responsibility includes making sure that our products reach people who need them, regardless of where they live or their ability to pay. So we’ve created many far-reaching
programs and partnerships to accomplish this. You can learn more about them at msd.com. The recent merger between MSD and Schering-Plough expands and strengthens our capabilities to help make the world a healthier place. Our goals are clear and our commitment is fierce. We are dedicated to solving problems and pursuing new answers
Our mission is to care & cure. We want to discover, develop and successfully market innovative products to prevent and cure diseases, to ease suffering, and to enhance the quality of life.
Our Vision: with more than 135 000 associates in 140 countries worldwide, Novartis associates share a vision of a better today and tomorrow for patients – a vision that drives our growth and success.
Healthcare Portfolio: Novartis has a diverse healthcare portfolio, including: innovative pharmaceuticals, eye care products, generics, consumer health products, animal health, vaccines & diagnostics.
In Egypt, Novartis has been present since 1962 under the name Swiss Pharma (JV between Ciba, Geigy, Sandoz, & Wander). In 1996, Novartis was created with the merger of Ciba Geigy& Sandoz. Novartis Egypt employs over 1,750 associates at the manufacturing site and scientific offices. The current pharma portfolio includes more than 60 products, many of which are leaders in their respective therapeutic areas including: hypertension & cardiovascular diseases, diabetes, oncology, organ transplant, neuroscience, ophthalmology, respiratory diseases, rheumatism & arthritis, critical care
October Pharma (OP) S.A.E is an Egyptian enterprise molded by global aspirations. This has always demanded a preparedness and long- term organizational vision that can encompass the turbulence’s and paradoxes of shifting terms and terrain’s of business
Trust, integrity and a shared passion to succeed are fundamental to any business relationship.
We strive to bring the best in quality to all those we come in contact with.
We strive for excellence in everything we do and look for continuous improvement in our processes and ourselves.
To keep up with your challenges, October Pharma has engaged the most professional employees
October Pharma is aiming to be a leading modern pharmaceutical company meeting the most advanced marketing, regulatory and pharmaceutical manufacturing standards to develop and manufacture proven high quality, effective and affordable generics in innovative drug delivery techniques.
October Pharma is to be among the top 10 employers of choice in Egypt in the pharmaceutical field and one of the top 10 pharmaceutical generic manufacturers in the Middle East in terms of sales within the coming 10 years. Also, October Pharma is to be seen as the partner of choice for licensing innovative pharmaceutical products in the region
Pfizer was the first research based pharmaceutical company to establish a joint venture project in Egypt in 1961, and currently we have a work force of more than 1000 Egyptians including pharmacists, economists, physicians and science graduates As a subsidiary of Pfizer Incorporated in New York, a leading international research based pharmaceutical company in the world. Pfizer Inc discovers, develops, manufactures, and markets leading prescription medicines for humans and animals and many of the world’s best-known consumer brands. Our innovative, value-added products improve the quality of people’s life around the world and help them enjoy longer, healthier, and more productive lives. The company has three business segments: health care, animal health and consumer health care. Our products are available in more than 150 countries. Pfizer has become the undisputed leader in our industry. We will become the world’s most valued company to patients, customers, colleagues, investors, business partners, and the communities where we work and live, by dedicating ourselves to humanity’s quest for longer, healthier, happier lives through innovation in pharmaceutical, consumer, and animal health products.
“Sanofi is a diversified healthcare company, not only a pharmaceutical company. We act with all our partners to protect health, enhance life and respond to the hope of the 7 billion potential people in need. We do this through our people, primarily by providing medicines and vaccines.
Our ambition is to be a global sustainable healthcare partner focused on patients’ needs. We demonstrate leadership both in business achievements and in communities in which we operate. We wish to be recognized for our ability to transform scientific innovation into hope and solutions for patients.”